Oct 26 (Reuters) - An expert panel on Tuesday voted overwhelmingly to recommend the U.S. Food and Drug Administration authorize the Pfizer Inc (PFE.N) and BioNTech SE COVID-19 vaccine for children ages 5 to 11, saying the benefits of the shot outweigh the risks.

An authorization for that age group would be an important regulatory step toward reaching about 28 million children.

So that means about 28 children aged 5-11 just bought a winning ticket in the death-lottery.

With a further 1 in 45 000 suffering serious injuries - approx 622.

None of whom would have been badly affected by the actual coronavirus.

Are they then going to be given boosters every six months for the rest of their life? In which case we need to redo the above math.